Rebecca Landy, PhD; Li C. Cheung, PhD; Christine D. Berg, MD; Anil K. Chaturvedi, PhD; Hilary A. Robbins, PhD; Hormuzd A. Katki, PhD
Note: The Lung Cancer Death Risk Assessment Too was previously proposed in a manuscript coauthored by Drs. Cheung, Berg, Chaturvedi, and Katki.
Disclaimer: The National Institutes of Health had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. The authors are solely responsible for the views expressed in this article, which do not necessarily represent the views, decisions, or policies of the institutions with which the authors are affiliated.
Acknowledgment: The authors thank the reviewers, whose comments greatly improved the manuscript.
Financial Support: By the Intramural Research Program of the National Cancer Institute, National Institutes of Health.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3617.
Reproducible Research Statement: Study protocol: Not available. Statistical code and data set: Available from Dr. Landy (e-mail, firstname.lastname@example.org).
Landy R, Cheung LC, Berg CD, et al. Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States. Ann Intern Med. 2019;171:384–386. [Epub ahead of print 4 June 2019]. doi: https://doi.org/10.7326/M18-3617
Download citation file:
Published: Ann Intern Med. 2019;171(5):384-386.
Published at www.annals.org on 4 June 2019
Cancer Screening/Prevention, Hematology/Oncology, Lung Cancer, Prevention/Screening, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use